Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis

Published:2011-04-07 Issue:6 Volume:27 Page:1191-1210
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Mikhailidis Dimitri P.¹,Lawson Richard W.²,McCormick Anna-Louise²,Sibbring Gillian C.²,Tershakovec Andrew M.³,Davies Glenn M.³,Tunceli Kaan⁴

Affiliation:

1. Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), University College London (UCL) Medical School, London, UK

2. Complete Market Access, Macclesfield, UK

3. Merck Research Laboratories, West Point and Upper Gwynedd, PA, USA

4. Global Health Outcomes, Merck, Whitehouse Station, NJ, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2011.571239

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lowering of Blood Lipid Levels with a Combination of Pitavastatin and Ezetimibe in Patients with Coronary Heart Disease: A Meta-Analysis;Cardiovascular Innovations and Applications;2023

2. 2022: The Year in Cardiovascular Disease – The Year of Upfront Lipid Lowering Combination Therapy.;Archives of Medical Science;2022-10-28

3. A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia;Clinical Therapeutics;2022-10

4. Efficacy and safety of hybutimibe on primary hypercholesterolemia: a randomized, double-blinded, placebo and positive–controlled, parallel phase II study;Cardiology Plus;2022-04

5. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins;Journal of Cardiovascular Pharmacology and Therapeutics;2022-01-01